The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The effect of compliance with treatment on survival among patients with hematologic malignancies.
Abstract
Ninety-four newly diagnosed patients with hematologic malignancies were monitored for compliance with oral medication and scheduled clinic appointments over a 6-month treatment period. They were assigned at entry either to a control condition or an intervention condition designed to improve compliance. Compliance with medication was assessed objectively with serial serum drug and metabolite levels, as well as with self-report indices obtained on a monthly basis. Medical records were abstracted to obtain data on the number of appointments kept, treatment given, disease characteristics, and survival. On univariate analyses using the log-rank test, five variables were found to be significantly related to survival. These included compliance with allopurinol (probably acting as a surrogate for self-medication with other chemotherapeutic agents) (P = .007), control versus educational program cohort (P less than .001), disease severity (P = .009), Karnofsky at diagnosis (P = .011), sex (P = .084), and clinic appointments kept (P = .043). In hierarchical proportional hazards models, the following variables were associated with decreased risk of death: disease severity (P less than .025), keeping over 60% of appointments (P less than .05), allopurinol/oxipurinol compliance (P less than .01), and educational program cohort (P less than .05). After controlling for all other variables, three variables were associated with increased survival: high disease severity (relative risk [RR] = 2.48), high compliance with allopurinol (RR = .45), and educational program cohort (RR = .39). We conclude that compliance with oral medication has a significant effect on patient survival. In addition, the use of special educational and supportive programs designed to improve patient compliance are associated with significant prolongation of patient survival due to, as well as independent of their effects on compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1979) · Medical Entomology and Zoology · Cited by 11,252
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 2,143
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DEVITA, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,436
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma
McKelvey, E. M., Gottlieb, J. A., Wilson, H. E., Haut, A., Talley, R. W., Stephens, R., Lane, M., Gamble, J. F., Jones, S. E., Grozea, P. N., et al. (1976) · Cancer · doi:10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i · Cited by 820
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
SCHEIN, P. S., DeVITA, V. T., HUBBARD, S., CHABNER, B. A., CANELLOS, G. P., BERARD, C., & YOUNG, R. C. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-417 · Cited by 344
BAGLEY, C. M., DEVITA, V. T., BERARD, C. W., & CANELLOS, G. P. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-2-227 · Cited by 336
Skarin, A. T., Canellos, G. P., Rosenthal, D. S., Case, D. C., MacIntyre, J. M., Pinkus, G. S., Moloney, W. C., & Frei, E. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.2.91 · Cited by 334
Cited by
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Marital Status and Survival in Patients With Cancer
Aizer, A. A., Chen, M.-H., McCarthy, E. P., Mendu, M. L., Koo, S., Wilhite, T. J., Graham, P. L., Choueiri, T. K., Hoffman, K. E., Martin, N. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6489 · Cited by 1,031
Fawzy, F. I. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210015002 · Cited by 1,028
Effectiveness of Interventions to Improve Patient Compliance: A Meta-Analysis
Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., & Svarstad, B. (1998) · Medical Care · doi:10.1097/00005650-199808000-00004 · Cited by 995
Depression and cancer: mechanisms and disease progression
Spiegel, D., & Giese-Davis, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00566-3 · Cited by 874
Kato, P. M., Cole, S. W., Bradlyn, A. S., & Pollock, B. H. (2008) · Pediatrics · doi:10.1542/peds.2007-3134 · Cited by 802
Critical Review of Psychosocial Interventions in Cancer Care
Fawzy, F. I. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140018003 · Cited by 560
Paterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Depression in Patients With Cancer: Diagnosis, Biology, and Treatment
McDaniel, J. S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140007002 · Cited by 534
Mind-Body Medicine: State of the Science, Implications for Practice
Astin, J. A., Shapiro, S. L., Eisenberg, D. M., & Forys, K. L. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.2.131 · Cited by 517
Associations of social networks with cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.06.003 · Cited by 460
Kissane, D. W., Grabsch, B., Clarke, D. M., Smith, G. C., Love, A. W., Bloch, S., Snyder, R. D., & Li, Y. (2007) · Psycho-Oncology · doi:10.1002/pon.1185 · Cited by 376
“Treatment-induced improvements in adherence [12] were relevant to survival in Richardson’s sequential cohort study [5], but not Spiegel’s SEGT trial [13].”
BackgroundPsychoeducation as Evidence-Based Practice: Considerations for Practice, Research, and Policy
Lukens, E. P., & McFarlane, W. R. (2004) · Brief Treatment and Crisis Intervention · doi:10.1093/brief-treatment/mhh019 · Cited by 361
Spiegel, D. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298486 · Cited by 303
Spiegel, D., Butler, L. D., Giese‐Davis, J., Koopman, C., Miller, E., DiMiceli, S., Classen, C. C., Fobair, P., Carlson, R. W., & Kraemer, H. C. (2007) · Cancer · doi:10.1002/cncr.22890 · Cited by 290
Cunningham, A. J., Edmonds, C. V. I., Jenkins, G. P., Pollack, H., Lockwood, G. A., & Warr, D. (1998) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199811/12)7:6<508::aid-pon376>3.0.co;2-7 · Cited by 277
Gripp, S., Moeller, S., Bölke, E., Schmitt, G., Matuschek, C., Asgari, S., Asgharzadeh, F., Roth, S., Budach, W., Franz, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5411 · Cited by 277
Research-informed psychotherapy
Grawe, K. (1997) · Psychotherapy Research · doi:10.1080/10503309712331331843 · Cited by 269
Social relations, social support and survival among patients with cancer
Ell, K., Nishimoto, R., Mediansky, L., Mantell, J., & Hamovitch, M. (1992) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(92)90038-4 · Cited by 266
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (2002) · Foundations in Social Neuroscience · doi:10.7551/mitpress/3077.003.0079 · Cited by 255
Psychological interventions for women with metastatic breast cancer
Mustafa, M., Carson-Stevens, A., Gillespie, D., & Edwards, A. G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004253.pub4 · Cited by 244
Hulbert-Williams, N. J., Storey, L., & Wilson, K. G. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12223 · Cited by 228
Assessment and treatment of depression in the cancer patient
Newport, D. J., & Nemeroff, C. B. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00011-7 · Cited by 167
Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study
Pirl, W. F., Siegel, G. I., Goode, M. J., & Smith, M. R. (2002) · Psycho-Oncology · doi:10.1002/pon.592 · Cited by 149
Bordeleau, L., Szalai, J. P., Ennis, M., Leszcz, M., Speca, M., Sela, R., Doll, R., Chochinov, H. M., Navarro, M., Arnold, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.080 · Cited by 148
Kissane, D. (2009) · Psycho-Oncology · doi:10.1002/pon.1493 · Cited by 136
Ell, K., Vourlekis, B., Xie, B., Nedjat‐Haiem, F. R., Lee, P., Muderspach, L., Russell, C., & Palinkas, L. A. (2009) · Cancer · doi:10.1002/cncr.24500 · Cited by 132
Minding the body: Psychotherapy and cancer survival
Spiegel, D. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12061 · Cited by 53
Essentials of psychotherapeutic intervention for cancer patients
Seiegel, D. (1995) · Supportive Care in Cancer · doi:10.1007/bf00335899 · Cited by 48
Spiegel, D. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00576-2 · Cited by 12
Metadata
- Authors
- Richardson, J. L., Shelton, D. R., Krailo, M., & Levine, A. M.
- Venue
- Journal of Clinical Oncology
- Published
- 1990-02
- Volume
- 8
- Issue
- 2
- Pages
- 356-364
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2178871496
- Cited by
- 305
- References
- 24
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.